Can I read Financial Disclosure by Clinical Investigators on EtoBox?
Financial Disclosure by Clinical Investigators by Ivan Alejandro Pulido Tarquino is a document available to read on EtoBox.
What is Financial Disclosure by Clinical Investigators about?
21 CFR Part 54 outlines the financial disclosure requirements for clinical investigators involved in studies submitted for FDA marketing applications. It mandates that applicants disclose financial arrangements and interests of investigators to minimize bias in clinical studies. The FDA evaluates these disclosures to assess the reliability of the data and may take actions to ensure data integrity if financial interests raise concerns.
- Author
- Ivan Alejandro Pulido Tarquino
- Language
- EN